• Annette L Briley, Suzanne Barr, Shirlene Badger, Ruth Bell, Helen Croker, Keith M Godfrey, Bridget Holmes, Tarja I Kinnunen, Scott M Nelson, Eugene Oteng-Ntim, Nashita Patel, Stephen C Robson, Jane Sandall, Thomas Sanders, Naveed Sattar, Paul T Seed, Jane Wardle, and Lucilla Poston.
• Division of Women's Health, Women's Health Academic Centre, King's College London and King's Health Partners, 10th floor, North Wing, St,Thomas' Hospital, London SE1 7EH, UK. lucilla.poston@kcl.ac.uk.
• Bmc Pregnancy Childb. 2014 Jan 1;14:74.

BackgroundDespite the widespread recognition that obesity in pregnant women is associated with adverse outcomes for mother and child, there is no intervention proven to reduce the risk of these complications. The primary aim of this randomised controlled trial is to assess in obese pregnant women, whether a complex behavioural intervention, based on changing diet (to foods with a lower glycemic index) and physical activity, will reduce the risk of gestational diabetes (GDM) and delivery of a large for gestational age (LGA) infant. A secondary aim is to determine whether the intervention lowers the long term risk of obesity in the offspring.Methods/DesignMulticentre randomised controlled trial comparing a behavioural intervention designed to improve glycemic control with standard antenatal care in obese pregnant women.Inclusion criteria; women with a BMI ≥30 kg/m2 and a singleton pregnancy between 15+0 weeks and 18+6 weeks' gestation. Exclusion criteria; pre-defined, pre-existing diseases and multiple pregnancy. Randomisation is on-line by a computer generated programme and is minimised by BMI category, maternal age, ethnicity, parity and centre. Intervention; this is delivered by a health trainer over 8 sessions. Based on control theory, with elements of social cognitive theory, the intervention is designed to improve maternal glycemic control. Women randomised to the control arm receive standard antenatal care until delivery according to local guidelines. All women have a 75 g oral glucose tolerance test at 27+0- 28+6 weeks' gestation.Primary outcome; Maternal: diagnosis of GDM, according to the International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria. Neonatal; infant LGA defined as >90th customised birth weight centile.Sample size; 1546 women to provide 80% power to detect a 25% reduction in the incidence of GDM and a 30% reduction in infants large for gestational age.DiscussionAll aspects of this protocol have been evaluated in a pilot randomised controlled trial, with subsequent optimisation of the intervention. The findings of this trial will inform whether lifestyle mediated improvement of glycemic control in obese pregnant women can minimise the risk of pregnancy complications.Trial RegistrationCurrent controlled trials; ISRCTN89971375.

34 keywords...

hide…